Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Florence

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Plos One|August 24, 2017
A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screeningAnja De Weggheleire, Sokkab An, Irith De Baetselier, et al.
Plos One|April 27, 2017
A randomized trial comparing concise and standard consent forms in the START trialChristine Grady, Giota Touloumi, A Sarah Walker, et al.
AIDS Research and Therapy|October 23, 2025
Epidemiological, clinical, and biological profiles of People Living With HIV in the PMTCT department of Panzi hospital: a retrospective cohort study in Eastern DR. CongoBerckmans Mukanire Ntakwinja, Patrick D M C Katoto, Lampard Omari Mukanga, et al.
Journal of the International AIDS Society|August 19, 2024
The impact of analytical treatment interruptions and trial interventions on time to viral re-suppression in people living with HIV restarting ART in cure-related clinical studies: a systematic review and meta-analysisMing Jie Lee, Miles Eason, Antonella Castagna, et al.
BMC Infectious Diseases|December 3, 2022
Impact of COVID-19 on the Belgian HIV epidemic: slowdown of HIV transmission and testing and adaptation of careDominique Van Beckhoven, Ben Serrien, Marion Montourcy, et al.
Journal of the International AIDS Society|February 29, 2020
Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on-going viral transcriptionPieter Pannus, Sofie Rutsaert, Stéphane De Wit, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2004
Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment responseInge Derdelinckx, Kristel Van Laethem, Bart Maes, et al.
AIDS Research and Therapy|September 1, 2010
HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assaysIna Vandenbroucke, Herwig Van Marck, Wendy Mostmans, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Role of Baseline pol Genotype in HIV-1 Fitness EvolutionJan Weber, Hector R Rangel, Bikram Chakraborty, et al.
AIDS (London, England)|November 8, 2017
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular riskJosé M Gatell, Lambert Assoumou, Graeme Moyle, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Plos One|August 24, 2017
A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screeningAnja De Weggheleire, Sokkab An, Irith De Baetselier, et al.
Plos One|April 27, 2017
A randomized trial comparing concise and standard consent forms in the START trialChristine Grady, Giota Touloumi, A Sarah Walker, et al.
AIDS Research and Therapy|October 23, 2025
Epidemiological, clinical, and biological profiles of People Living With HIV in the PMTCT department of Panzi hospital: a retrospective cohort study in Eastern DR. CongoBerckmans Mukanire Ntakwinja, Patrick D M C Katoto, Lampard Omari Mukanga, et al.
Journal of the International AIDS Society|August 19, 2024
The impact of analytical treatment interruptions and trial interventions on time to viral re-suppression in people living with HIV restarting ART in cure-related clinical studies: a systematic review and meta-analysisMing Jie Lee, Miles Eason, Antonella Castagna, et al.
BMC Infectious Diseases|December 3, 2022
Impact of COVID-19 on the Belgian HIV epidemic: slowdown of HIV transmission and testing and adaptation of careDominique Van Beckhoven, Ben Serrien, Marion Montourcy, et al.
Journal of the International AIDS Society|February 29, 2020
Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on-going viral transcriptionPieter Pannus, Sofie Rutsaert, Stéphane De Wit, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2004
Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment responseInge Derdelinckx, Kristel Van Laethem, Bart Maes, et al.
AIDS Research and Therapy|September 1, 2010
HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assaysIna Vandenbroucke, Herwig Van Marck, Wendy Mostmans, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Role of Baseline pol Genotype in HIV-1 Fitness EvolutionJan Weber, Hector R Rangel, Bikram Chakraborty, et al.
AIDS (London, England)|November 8, 2017
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular riskJosé M Gatell, Lambert Assoumou, Graeme Moyle, et al.
Pageof 12